The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 2, 2007, Pages 521-528

  Keogh, Christine L ^a   Shan, Ping Yu ^a,b   Wei, Ling ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR; BROXURIDINE; GLUCOSE TRANSPORTER 1; NEURONAL MARKER PROTEIN; PROTEIN; RECOMBINANT ERYTHROPOIETIN; TIE 1 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN REGION; CELL COUNT; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; NERVE CELL; NERVE REGENERATION; NEUROPROTECTION; NEWBORN; NEWBORN PERIOD; NICK END LABELING; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; STROKE; TREATMENT OUTCOME; WESTERN BLOTTING;

ANGIOPOIETIN-2; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BLOTTING, WESTERN; CAROTID ARTERIES; CELL PROLIFERATION; CEREBRAL ARTERIES; CEREBROVASCULAR ACCIDENT; ENDOTHELIAL CELLS; ERYTHROPOIETIN, RECOMBINANT; FIBROBLAST GROWTH FACTOR 2; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; LIGATION; NEOVASCULARIZATION, PHYSIOLOGIC; NERVOUS SYSTEM; NEURONS; RATS; RATS, WISTAR; RECEPTOR, TIE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34547119289     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.121392     Document Type: Article

References (41)

1. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, and Petit E (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab 19:643-651.
2. Blomgren K, Zhu C, Hallin U, and Hagberg H (2003) Mitochondria and ischemic reperfusion damage in the adult and in the developing brain. Biochem Biophys Res Commun 304:551-559.
3. Chong ZZ, Kang JQ, and Maiese K (2002) Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106:2973-2979.
4. Cimino M, Balduini W, Carloni S, Gelosa P, Guerrini U, Tremoli E, and Sironi L (2005) Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. Neurotoxicology 26:929-933.
5. Curin Y, Ritz MF, and Andriantsitohaina R (2006) Cellular mechanisms of the protective effect of polyphenols on the neurovascular unit in strokes. Cardiovasc Hematol Agents Med Chem 4:277-288.
6. Danneman PJ and Mandrell TD (1997) Evaluation of five agents/methods for anesthesia of neonatal rats. Lab Anim Sci 47:386-395.
7. Demers EJ, McPherson RJ, and Juul SE (2005) Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 58:297-301.
8. Derugin N, Wendland M, Muramatsu K, Roberts TP, Gregory G, Ferriero DM, and Vexler ZS (2000) Evolution of brain injury after transient middle cerebral artery occlusion in neonatal rats. Stroke 31:1752-1761.
9. Dührsen U and Hossfeld DK (1994) Hematopoietic growth factors and the treatment of tumor-associated anemias. Ann Hematol 69:213-221.
10. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, et al. (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495-505.
11. Farrell F and Lee A (2004) The erythropoietin receptor and its expression in tumor cells and other tissues. Oncologist 9 (Suppl 5):18-30.
12. Folkman J and Klagsbrun M (1987) Angiogenic factors. Science 235:442-447.
13. Grote K, Luchtefeld M, and Schieffer B (2005) JANUS under stress-role of JAK/STAT signaling pathway in vascular diseases. Vascul Pharmacol 43:357-363.
14. Gumy-Pause F, Ozsahin H, Mermillod B, Cingria L, Berner M, and Wacker P (2005) Stepping up versus standard doses of erythropoietin in preterm infants: a randomized controlled trial. Pediatr Hematol Oncol 22:667-678.
15. Hill IE, MacManus JP, Rasquinha I, and Tuor UI (1995) DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat. Brain Res 676:398-403.
16. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed., Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
17. Johnston MV, Trescher WH, Ishida A, and Nakajima W (2001) Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res 49:735-741.
18. Lemasson M, Saghatelyan A, Olivo-Marin JC, and Lledo PM (2005) Neonatal and adult neurogenesis provide two distinct populations of newborn neurons to the mouse olfactory bulb. J Neurosci 25:6816-6825.
19. Li Y, Lu Z, Keogh CL, Yu SP, and Wei L (2007) Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 27:1043-1054.
20. McPherson RJ, Demers EJ, and Juul SE (2007) Safety of high-dose recombinant erythropoietin in a neonatal rat model. Neonatology 91:36-43.
21. Mudò G, Belluardo N, Mauro A, and Fuxe K (2007) Acute intermittent nicotine treatment induces fibroblast growth factor-2 in the subventricular zone of the adult rat brain and enhances neuronal precursor cell proliferation. Neuroscience 145: 470-483.
22. Muller-Ehmsen J, Schmidt A, Krausgrill B, Schwinger RH, and Bloch W (2006) Role of erythropoietin for angiogenesis and vasculogenesis: from embryonic development through adulthood. Am J Physiol 290:H331-H340.
23. Nakajima W, Ishida A, Lange MS, Gabrielson KL, Wilson MA, Martin LJ, Blue ME, and Johnston MV (2000) Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 20:7994-8004.
24. Nelson KB and Lynch JK (2004) Stroke in newborn infants. Lancet Neurol 3:150-158.
25. Northington FJ (2006) Brief update on animal models of hypoxic-ischemic encephalopathy and neonatal stroke. Ilar J 47:32-38.
26. Ogunshola OO, Stewart WB, Mihalcik V, Solli T, Madri JA, and Ment LR (2000) Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res Dev Brain Res 119:139-153.
27. Ohab JJ, Fleming S, Blesch A, and Carmichael ST (2006) A neurovascular niche for neurogenesis after stroke. J Neurosci 26:13007-13016.
28. Ozduman K, Pober BR, Barnes P, Copel JA, Ogle EA, Duncan CC, and Ment LR (2004) Fetal stroke. Pediatr Neurol 30:151-162.
29. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, Vincent P, Pumiglia K, and Temple S (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304:1338-1340.
30. Shweiki D, Itin A, Soffer D, and Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
31. Sinor AD and Greenberg DA (2000) Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity. Neurosci Lett 290:213-215.
32. Sola A, Wen TC, Hamrick SE, and Ferriero DM (2005) Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr Res 57:110R-117R.
33. Sun Y, Calvert JW, and Zhang JH (2005) Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration. Stroke 36:1672-1678.
34. + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114:330-338.
35. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, et al. (2003) Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198:971-975.
36. Wei L, Han BH, Li Y, Keogh CL, Holtzman DM, and Yu SP (2006) Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Exp Ther 317:109-116.
37. Wei L, Keogh CL, Whitaker VR, Theus MH, and Yu SP (2005) Angiogenesis and stem cell transplantation as potential treatments of cerebral ischemic stroke. Pathophysiology 12:47-62.
38. Wen TC, Rogido M, Gressens P, and Sola A (2004) A reproducible experimental model of focal cerebral ischemia in the neonatal rat. Brain Res Brain Res Protoc 13:76-83.
39. Whitaker VR, Cui L, Miller S, Yu SP, and Wei L (2007) Whisker stimulation enhances angiogenesis in the barrel cortex following focal ischemia in mice. J Cereb Blood Flow Metab 27:57-68.
40. Xiao Z, Kong Y, Yang S, Li M, Wen J, and Li L (2007) Upregulation of Flk-1 by bFGF via the ERK pathway is essential for VEGF-mediated promotion of neural stem cell proliferation. Cell Res 17:73-79.
41. Zhang F, Wang S, Cao G, Gao Y, and Chen J (2007) Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia. Neurobiol Dis 25:45-53.